MedPath

TAZORAC

These highlights do not include all the information needed to use TAZORAC Gel safely and effectively. See full prescribing information for TAZORAC Gel. TAZORAC (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997

Approved
Approval ID

75145c21-6ef2-455a-8a67-d48ddd4181a4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 16, 2018

Manufacturers
FDA

Allergan, Inc.

DUNS: 144796497

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

tazarotene

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0023-0042
Application NumberNDA020600
Product Classification
M
Marketing Category
C73594
G
Generic Name
tazarotene
Product Specifications
Route of AdministrationCUTANEOUS
Effective DateNovember 20, 2023
FDA Product Classification

INGREDIENTS (13)

TAZAROTENEActive
Quantity: 1 mg in 1 g
Code: 81BDR9Y8PS
Classification: ACTIB
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171K
Classification: IACT
ASCORBIC ACIDInactive
Code: PQ6CK8PD0R
Classification: IACT
HEXYLENE GLYCOLInactive
Code: KEH0A3F75J
Classification: IACT
POLOXAMER 407Inactive
Code: TUF2IVW3M2
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
TROMETHAMINEInactive
Code: 023C2WHX2V
Classification: IACT
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2U
Classification: IACT
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)Inactive
Code: HHT01ZNK31
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
POLYSORBATE 40Inactive
Code: STI11B5A2X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

tazarotene

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0023-8335
Application NumberNDA020600
Product Classification
M
Marketing Category
C73594
G
Generic Name
tazarotene
Product Specifications
Route of AdministrationCUTANEOUS
Effective DateNovember 20, 2023
FDA Product Classification

INGREDIENTS (13)

BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
ASCORBIC ACIDInactive
Code: PQ6CK8PD0R
Classification: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171K
Classification: IACT
HEXYLENE GLYCOLInactive
Code: KEH0A3F75J
Classification: IACT
POLYSORBATE 40Inactive
Code: STI11B5A2X
Classification: IACT
POLOXAMER 407Inactive
Code: TUF2IVW3M2
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
TAZAROTENEActive
Quantity: 0.5 mg in 1 g
Code: 81BDR9Y8PS
Classification: ACTIB
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2U
Classification: IACT
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)Inactive
Code: HHT01ZNK31
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
TROMETHAMINEInactive
Code: 023C2WHX2V
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.